AB Science SA announced that it has postponed the publication of its 2023 annual financial report, initially scheduled for April 30, 2024, to give the auditors time to complete their audit work. The Company will publish its 2023 annual financial report no later than May 15, 2024, after trading.
Market Closed -
Other stock markets
|
After market 11:47:53 pm | |||
2.28 EUR | +8.57% | 2.28 | 0.00% |
13/05 | AB Science: European patent granted for masitinib | CF |
03/05 | AB Science: upbeat after legal success | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.86% | 12Cr | |
+15.09% | 7.45TCr | |
+11.35% | 918Cr | |
+54.35% | 503.01Cr | |
-12.85% | 502.18Cr | |
+1.60% | 382.03Cr | |
-20.85% | 240.99Cr | |
+16.88% | 239.16Cr | |
-29.25% | 227.4Cr | |
+24.62% | 226.23Cr |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science S.A. Announces Slight Delay in Publication of Annual Financial Report 2023